DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Nephro Care India Limited — Reply to Clarification- Financial results

NSE 2 hrs ago·1 Sept 2026, 12:32 pm

Nephro Care India

Nephro Care India Limited has submitted a clarification to the stock exchanges regarding its unaudited financial results for the quarter ended June 30, 2026. The company was asked to provide details under Regulation 33 of the SEBI Listing Obligations Regulations, which requires listed entities to disclose specific financial information to ensure transparency for investors.

This disclosure is a standard regulatory requirement and does not indicate any new information about the company's performance. The clarification is aimed at keeping the market informed and maintaining high standards of corporate governance. It is a routine procedural step that helps investors assess the company's financial standing accurately.

Investors should wait for the full financial results to be released to get a complete picture of the company's performance. This clarification alone does not signal any significant change in the company's operational or financial outlook. Monitoring the official filing will provide the most relevant data for decision-making.